Evidence map›Paper›PMID 40380037›Full record

ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2025

Long-term follow up of single-chamber atrial pacing-system upgrade and Wenckebach block point behavior: potential implications for leadless AAI pacing?

Patrick Badertscher, Rebecca Arnet, Corinne Isenegger, Behnam Subin, Sven Knecht, Jessica Trussardi, Philipp Krisai, Felix Mahfoud, Christian Sticherling, Beat Schär and 1 more

Abstract read
In one paragraph

Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Patrick BadertscherDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland. patrick.badertscher@usb.ch.ORCID http://orcid.org/0000-0001-9751-0557
Rebecca ArnetDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Corinne IseneggerDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Behnam SubinDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Sven KnechtDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Jessica TrussardiDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Philipp KrisaiDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Felix MahfoudDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Christian SticherlingDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Beat SchärDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Michael KühneDepartment of Cardiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSingle chamber atrial pacing (AAI) provides a disease-specific treatment for sick sinus syndrome (SSS) but has largely been replaced by DDD pacing. With the advent of leadless atrial pacemakers (PM), there is growing interest in long-term follow-up data in patients with SSS and an AAI pacemaker. PURPOSE: To assess the incidence of system upgrade in patients treated with AAI-PM for SSS during long-term follow-up.

methodsThis is an analysis of prospectively enrolled patients undergoing implantation of an AAI-PM. Wenckebach block point (WBP) was measured at implantation and serially during follow up.

resultsWe included 178 patients (58% female, median age at implantation 77 [71-83] years). The median follow-up duration was 6.5 [2.0-9.7] years. Twenty-three patients (13%) received a system upgrade to a DDD system, corresponding to a yearly upgrade rate of 2.0%. Median time to system upgrade was 5.2 [1.6-8.7] years. Reasons for system upgrade were higher-degree AVB (39%), atrial arrhythmias (35%), low WBP (17%), and syncope (9%). Median WBP at implantation was 130 [120-140] bpm, showing a significant decline over time in the upgrade-group compared to the rest of the cohort with 103 [91-130] bpm vs. 130 [120-130] bpm (p = 0.011).

conclusionIn this cohort of patients undergoing AAI-PM implantation for SSS, upgrade to a DDD system was low during long-term follow-up. Therefore, AAI pacing for the treatment of SSS may be considered a patient-tailored treatment option, especially in light of novel leadless pacing therapies.

Indexed as

Cardiac Pacing, ArtificialPacemaker, ArtificialSick Sinus SyndromeAgedAged, 80 and overEquipment DesignFemaleFollow-Up StudiesHeart AtriaHumansMaleProspective StudiesTreatment OutcomeAAI-pacingLeadless pacingPacemakerSick sinus syndrome

Identifiers

PMID40380037
PMCPMC12476441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.